MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Fibrocell Science Company Profile (NASDAQ:FCSC)

Consensus Ratings for Fibrocell Science (NASDAQ:FCSC) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $4.94 (336.95% upside)

Analysts' Ratings History for Fibrocell Science (NASDAQ:FCSC)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Canaccord GenuityReiterated RatingBuy$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Griffin SecuritiesReiterated RatingBuy$9.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Fibrocell Science (NASDAQ:FCSC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q1($0.15)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q415($0.17)($0.40)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.16)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015($0.16)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2015($0.16)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q3 14($0.14)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.18)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/19/2014Q114($0.15)($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Fibrocell Science (NASDAQ:FCSC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.14)($0.16)
Q2 20163($0.13)($0.09)($0.12)
Q3 20163($0.23)($0.06)($0.14)
Q4 20163($0.24)($0.07)($0.15)
Q1 20173($0.20)($0.07)($0.14)
Q2 20173($0.20)($0.07)($0.15)
Q3 20173($0.21)($0.05)($0.14)
Q4 20172($0.17)($0.05)($0.11)
(Data provided by Zacks Investment Research)
Dividend History for Fibrocell Science (NASDAQ:FCSC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Fibrocell Science (NASDAQ:FCSC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Fibrocell Science (NASDAQ:FCSC)
DateHeadline
06/30/16 05:47 AMAnalyst Rating Update on Fibrocell Science Inc (FCSC) - TheFounders Daily
06/29/16 08:58 PMWatching Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
06/29/16 08:58 PMFibrocell Science (FCSC) Updates on Azficel-T Wind-Down; Expects 'Significant' Cost Savings - StreetInsider.com
06/29/16 08:58 PMStock Tracking Lower in Session: Fibrocell Science, Inc. (NASDAQ:FCSC) - Telanagana Press
06/29/16 03:56 PMFibrocell Expects Significant Cost Savings from Wind-Down of azficel-T Operations
06/29/16 05:52 AMHC Stocks Impression: Fibrocell Science Inc (NASDAQ:FCSC), Pfizer Inc. (NYSE:PFE) - share market updates (press release)
06/28/16 03:57 PMChecking on Unusual Volume for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
06/28/16 03:57 PMWatch List: Fibrocell Science, Inc. (NASDAQ:FCSC), Cobalt International Energy, Inc. (NYSE:CIE), Alcoa Inc. (NYSE:AA ... - KC Register
06/28/16 03:57 PMTraders Alert: ON Semiconductor Corp (NASDAQ:ON), Fibrocell Science Inc (NASDAQ:FCSC) - NYSE Journal (press release)
06/28/16 03:57 PMAnalysis under consideration: Fibrocell Science, Inc. (NASDAQ:FCSC) - News Oracle
06/28/16 03:57 PMStocks Analysts Ranking Summary: Fibrocell Science Inc (NASDAQ:FCSC) , GW Pharmaceuticals Plc (NASDAQ:GWPH) - Street Updates
06/27/16 04:10 PMFIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot -
06/27/16 02:24 PMETF’s with exposure to Fibrocell Science, Inc. : June 27, 2016 -
06/24/16 04:03 PMStock in Oversold Area: Fibrocell Science, Inc. (NASDAQ:FCSC) - Press Telegraph
06/24/16 04:03 PMShares Dropping to a Recent Low: Fibrocell Science, Inc. (NASDAQ:FCSC) - Press Telegraph
06/23/16 04:46 AMStrong Buy Calls Count For Fibrocell Science Inc (NASDAQ:FCSC) At 2 - Investor Newswire
06/16/16 04:00 PMFibrocell Science Inc. (NASDAQ: FCSC) Kicks The Ball Rolling On FCX-007 - Scibility Media
06/13/16 03:46 PMFibrocell Science (FCSC) Commences Recruitment for FCX-007 Phase 1/2 as RDEB Treatment - StreetInsider.com
06/09/16 04:01 PMMarket Moving Stocks Update: Fibrocell Science, Inc. (NASDAQ:FCSC), Amazon.com, Inc. (NASDAQ:AMZN) - Beacon Chronicle
06/09/16 06:47 AMFDA Panel Nod For PFE, INSM Withdraws MAA, FCSC's Voice Fades Out
06/08/16 04:11 PMFibrocell: Phase 2 Azficel-T Vocal Cord Scarring Trial Fails To Meet Targets
06/08/16 04:11 PMFibrocell shares drop after clinical trial undershoots expectations
06/08/16 04:11 PMFibrocell Science (FCSC) Reports Azficel-T Phase 2 in Vocal Cord Scarring Missed Primary Endpoints
06/03/16 04:13 PMMoSys, Inc. (NASDAQ:MOSY) Went Down -0.26%: Fibrocell Science, Inc. (NASDAQ:FCSC), Exelixis, Inc. (NASDAQ ... - KC Register
05/25/16 08:42 AMCould Fibrocell Science Inc Change Direction After Reaching All-Time Low? - Wall Street Hints and News - Could Fibrocell Science Inc Change Direction After Reaching All-Time Low?Wall Street Hints and NewsThe stock of Fibrocell Science Inc (NASDAQ:FCSC) reached all time low today, May, 25 and still has $1.80 target or 13.00% below today's $2.07 share price. This indicates more downside for the $92.17M company. This technical setup was reported by ...
05/24/16 05:31 PMRoth Resumes Coverage On Fibrocell With Buy Rating, $7 Target - Fibrocell Science Inc (NASDAQ: FCSC) is leveraging its expertise with fibroblasts to target monogenic diseases as well as broader indications. Roth Capital Partners’ Joseph Pantginis resumed coverage of the company with a Buy rating and a $7 price target.
05/20/16 10:47 AMETF’s with exposure to Fibrocell Science, Inc. : May 20, 2016 -
05/20/16 09:00 AMLatest Analyst Ratings For Fibrocell Science Inc (FCSC) - Share Trading News - Latest Analyst Ratings For Fibrocell Science Inc (FCSC)Share Trading NewsFibrocell Science Inc has a 50 day moving average of 2.54 and a 200 day moving average of 3.39. The stock's market capitalization is 89.11M, it has a 52-week low of 2.00 and a 52-week high of 7.60. The share price of the company (FCSC) was down -0.98% ...
05/19/16 10:38 PMFibrocell Science Incorporated (NASDAQ:FCSC) Shorted Shares Increased 9.63% After Market Selling - Wall Street Hints and News - Fibrocell Science Incorporated (NASDAQ:FCSC) Shorted Shares Increased 9.63% After Market SellingWall Street Hints and NewsThe short interest to Fibrocell Science Incorporated's float is 17.22%. The stock is down 2.44% or $0.05 after the news, hitting $2 per share. About 33,787 shares traded hands. Fibrocell Science Inc (NASDAQ:FCSC) has declined 51.54% since October 13, ...
05/18/16 10:33 PMRevenue Update on Fibrocell Science Inc(NASDAQ:FCSC) - Trade Calls - Revenue Update on Fibrocell Science Inc(NASDAQ:FCSC)Trade CallsFibrocell Science Inc(NASDAQ:FCSC) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 5, 2016. Company reported revenue of $16.00K. Analysts estimated a revenue of $110.00K. Earnings per ...
05/17/16 05:19 PMAlpha One Assigns Impact Score Of 45 To Fibrocell Science Inc (NASDAQ:FCSC) - RealistInvestor.com - Alpha One Assigns Impact Score Of 45 To Fibrocell Science Inc (NASDAQ:FCSC)RealistInvestor.comAlpha One analyzed the various web articles published on Fibrocell Science Inc (NASDAQ:FCSC), and thereafter it gave company a daily sentiment score of 0.155. The entity designs algorithm based assessment to known stock sentiment on stock after ...
05/17/16 11:42 AMFibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 09:14 AMBroker Outlook For The Week Ahead Fibrocell Science Inc (FCSC) - Share Trading.News - Share Trading News - Broker Outlook For The Week Ahead Fibrocell Science Inc (FCSC) - Share Trading.NewsShare Trading NewsFibrocell Science Inc (FCSC) has decreased by -48.51% over 12 months. Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, ...Fibrocell Science Inc (NASDAQ:FCSC) Basic Consolidated EPS At $-0.8168Vanguard TribuneFibrocell Science Incorporated (NASDAQ:FCSC) Sellers Increased By 9.63% Their ShortsWall Street Hints and Newsall 3 news articles »
05/10/16 05:43 PMFibrocell Science Inc (NASDAQ:FCSC) Latest Impact Score At 67 - RealistInvestor.com - Fibrocell Science Inc (NASDAQ:FCSC) Latest Impact Score At 67RealistInvestor.comFibrocell Science Inc (NASDAQ:FCSC) has a 0.2 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published on different ...and more »
05/10/16 03:28 PMIntrexon Announces First Quarter 2016 Financial Results - [at noodls] - - Quarterly revenues of $43.4 million and GAAP net loss of $64.4 million including non-cash charges of $50.6 million - - Consideration received for technology access fees, reimbursement of R&D services ...
05/08/16 11:01 PMBroker Outlook For The Week Ahead Fibrocell Science Inc (FCSC) - Share Trading News - Broker Outlook For The Week Ahead Fibrocell Science Inc (FCSC)Share Trading NewsBroker Outlook For The Week Ahead Fibrocell Science Inc (FCSC). By Brenton Akerman / in US Broker Ratings / on Sunday, 08 May 2016 04:59 PM / 0 Comments. The most recently updated broker views and price targets issued for Fibrocell Science Inc ...Research Analysts Offer Predictions for Fibrocell Science Inc's Q1 2017 Earnings (FCSC)Web Breaking NewsFibrocell Science's (FCSC) CEO David Pernock on Q1 2016 Results - Earnings Call TranscriptSeeking Alphaall 3 news articles »
05/05/16 11:10 PMBig Movers: Fibrocell Science, Inc. (NASDAQ:FCSC), Jacksonville Bancorp (NASDAQ:JXSB), Preferred Apartment ... - KC Register - Big Movers: Fibrocell Science, Inc. (NASDAQ:FCSC), Jacksonville Bancorp (NASDAQ:JXSB), Preferred Apartment ...KC RegisterOn 25 April, Fibrocell Science, Inc., (NASDAQ:FCSC), announced that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for FCX-013 for the treatment of localized scleroderma, a chronic autoimmune disease ...
05/05/16 06:01 PMIntrexon (XON): Stock Likely to Beat Estimates in Q1 Earnings - Earlier this year, the company announced that it has expanded its existing partnership with Fibrocell Science, Inc. (FCSC - Snapshot Report) by means of a new ECC for the development of genetically modified fibroblasts to treat chronic inflammatory and ...
05/05/16 07:31 AMFibrocell Reports First Quarter 2016 Financial Results and Operational Highlights - [at noodls] - EXTON, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting the ...
05/05/16 07:28 AMFibrocell Science reports 1Q loss -
05/05/16 07:01 AMFIBROCELL SCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E -
05/05/16 06:07 AMQ1 2016 Fibrocell Science Inc Earnings Release - Before Market Open -
05/02/16 06:03 PMFibrocell Science Inc (FCSC) Broker Price Targets For The Coming Week - Share Trading News - Fibrocell Science Inc (FCSC) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Fibrocell Science Inc (FCSC). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/30/16 04:11 AMWhat's Fibrocell Science Inc Downside After Today's Huge Decline? - B.O.D.Y Confidential - What's Fibrocell Science Inc Downside After Today's Huge Decline?B.O.D.Y ConfidentialThe stock of Fibrocell Science Inc (NASDAQ:FCSC) is a huge mover today! The stock decreased 8.00% or $0.24 during the last trading session, hitting $2.76. About 136,230 shares traded hands. Fibrocell Science Inc (NASDAQ:FCSC) has declined 57.47% ...
04/29/16 04:24 AMFibrocell Science Inc (NASDAQ:FCSC) Has An Impact Score Of 91 - Deutsche Bank cut their price target on shares of West Corp from $30.00 to $23.00 and set a "buy" rating on the stock in a research report on Wednesday, February 3rd. The stock's market capitalization is 10.37B, it has a 52-week low of 38.64 and a 52-week ...
04/28/16 07:31 AMFibrocell to Host Conference Call and Webcast on Thursday, May 5, 2016 to Discuss First Quarter 2016 Financial Results and Recent Operational Highlights - [at noodls] - EXTON, Pa., April 28, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting ...
04/26/16 06:04 PMFibrocell Science Inc (NASDAQ:FCSC) Has An Impact Score Of 91 - RealistInvestor.com - Fibrocell Science Inc (NASDAQ:FCSC) Has An Impact Score Of 91RealistInvestor.comFibrocell Science Inc (NASDAQ:FCSC) has been given a 0 daily sentiment score for the related articles published on web today. Alpha One offer algorithm-based analytics, which can help state stock sentiment based on the content published on different ...and more »
04/25/16 06:40 PMQLT Inc. (USA) (NASDAQ:QLTI) & Fibrocell Science (NASDAQ:FCSC) Stocks in the Spotlight - Wall Street 24 - QLT Inc. (USA) (NASDAQ:QLTI) & Fibrocell Science (NASDAQ:FCSC) Stocks in the SpotlightWall Street 24On Friday, Shares of QLT Inc. (USA) (NASDAQ:QLTI) lost -4.43% to $1.51. The share price is trading in a range of $1.42 – $1.58. The stock exchanged hands with 315,837 Million shares contrast to its average daily volume of 101,322 Million shares. QLT Inc.and more »
04/25/16 08:30 AMFibrocell Receives Orphan Drug Designation from the FDA for FCX-013 for the Treatment of Localized Scleroderma - [at noodls] - FCX-013 Gene-Therapy Product Candidate Offers Potential to Address Painful Fibrotic Disease EXTON, Pa., April 25, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and ...
04/21/16 07:24 AMFibrocell Announces Last Patient Visit for Primary Endpoint Analysis in Phase II Clinical Trial of azficel-T for the Treatment of Vocal Cord Scarring - [at noodls] - Primary Endpoint Results Expected in Second Quarter of 2016 Personalized Biologics Pipeline Advancing in Skin and Connective Tissue EXTON, Pa., April 21, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., ...
About Fibrocell Science

Fibrocell Science logoFibrocell Science, Inc. (Fibrocell) is an autologous cell therapy company focused on developing treatments for rare and serious skin and connective tissue diseases. The Company's lead orphan gene therapy program is in late-stage pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). In addition to its gene therapy program, the Company is pursuing the medical application of azficel-T for vocal cord scarring using its autologous fibroblast technology. The Company is also in pre-clinical development for its second gene therapy program for linear scleroderma. The Company's collaboration with Intrexon Corporation, a synthetic biology company, includes using genetically modifying autologous fibroblast cells to express collagen VII that is missing or inactive from patients with RDEB.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FCSC
  • CUSIP:
Key Metrics:
  • Previous Close: $1.19
  • 50 Day Moving Average: $1.63
  • 200 Day Moving Average: $2.61
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $49.60M
  • Current Quarter EPS Consensus Estimate: $-0.45 EPS
Additional Links:
Fibrocell Science (NASDAQ:FCSC) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha